 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Sequenom, Inc.
 |
Sequenom, Inc. |
 |
 |
 |
PROFILE |
 |
Gene sequencing is no dream sequence for Sequenom. The company seeks to shed light on the genetic underpinnings of life for uses in industrial genomics. Sequenom's MassARRAY sequencing system includes the SpectroREADER mass spectrometer, which analyzes variations in DNA called single nucleotide polymorphisms (SNPs). The company also makes SpectroCHIP silicon wafers, which are used with the MassARRAY system to analyze biomolecules, and SpectroTYPER, a software package that interprets the system's measurements. Sequenom's clients include the National Cancer Institute, GlaxoSmithKline, and contributors to the Human Genome Project, among others. It is buying British gene sequencer Gemini Genomics.
COMPETITION |
 |
APBiotech Inc (dossier)
Affymetrix, Inc. (AFFX)
Applera Corporation (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 10.00
1-Yr. Sales Growth: 4,900.0%
Employees: 198
Revenue per employee: $50,505.05
KEY PEOPLE |
 |
Antonius Schuh
CEO
Stephen L. Zaniboni
CFO
CONTACT INFO |
 |
3595 John Hopkins Court
San Diego, CA 92121
US
Phone: 858-202-9000
Fax: 858-202-9001
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |